The prognostic value of capillary glucose levels in acute stroke the GLycemia in acute stroke (GLIAS) study

Stroke

Volumn 40, Issue 2, 2009, Pages 562-568

  Fuentes, Blanca ^a   JoseCastillo ^b   José, Belén San ^a   Leira, Rogelio ^b   Serena, Joaquín ^c   JoseVivancos ^d   Dávalos, Antonio ^e   Nuñez, Antonio Gil ^f   JoseEgido ^g   Díez Tejedor, Exuperio ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Pediatric Nutrition Research Group Health Research Institute of Santiago de Compostela   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Acute stroke; Hyperglycemia; Outcome; Stroke care

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; BIOLOGICAL MARKER;

ACCURACY; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN INFARCTION SIZE; CAPILLARY BLOOD; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DEATH; DIABETES MELLITUS; DISEASE SEVERITY; DRUG DOSE TITRATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; RECEIVER OPERATING CHARACTERISTIC; RISK; SENSITIVITY AND SPECIFICITY; ACUTE DISEASE; CAPILLARY; CLASSIFICATION; CLINICAL TRIAL; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; ROC CURVE; STATISTICAL MODEL; STROKE; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CAPILLARIES; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; STROKE; TREATMENT OUTCOME;

EID: 60549108722     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.519926     Document Type: Article

References (34)

1. Lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke. 2004;35:363-364.
2. Fuentes B, Díez-Tejedor E. General care in stroke:relevance of glycemia and blood pressure levels. Cerebrovasc Dis. 2007;24:134-142.
3. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KGMM, Gray CS. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet. 1999;353:376-377.
4. Weir JW, Murria GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after stroke? Results of a long term follow up study. BMJ. 1997;314:1303-1306.
5. Els T, Klisch J, Orszagh M, Hetzel A, Schulte-Monting J, Schumacher M, Lucking CH. Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis:influence on clinical outcome and infarct size. Cerebrovasc Dis. 2002;13:89-94.
6. Alvarez-Sabín J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, Codina A, Quintana M. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke. 2003;34:1235-1241.
7. Baird TA, Parsons NW, Phanh T, Butcher KS, MacGregor L, Prosser J, Colman P, Davis SM. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34:2208-2214.
8. European Stroke Initiative Executive Committee and Writing Committee. The European Stroke Initiative recommendations for stroke management. Update 2003. Cerebrovasc Dis. 2003;16:311-318.
9. European Stroke Initiative. European Stroke Initiative recommendations for stroke management. Cerebrovasc Dis. 2000;10:335-351.
10. Bogousslavsky J, van Melle G, Regli F. The Lausanne Stroke Registry:analysis of 1000 consecutive patients with first stroke. Stroke. 1988:19:1083-1092.
11. Arboix A, Álvarez-Sabín J, Soler L. Stroke. Classification and diagnostic criteria. Ad hoc Editorial Committee of the Task Force on Cerebrovascular Diseases of SEN. Neurología. 1998;13(suppl 3):3-10.
12. Cote R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V. The Canadian Neurological Scale:validation and reliability assessment. Neurology. 1989;39:638-643.
13. Fieschi C. Argentino C, Lenzi GL. Sacchetti ML. Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci. 1989:91:311-321.
14. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ. van Gijn J. Inter-observer agreement for the assessment of handicap in stroke patients. Stroke. 1988:19:604-607.
15. Kasner S. Clinical interpretation and use of stroke scales. Lancet Neurol. 2006;5:603-612.
16. Christensen H, Boysen G. Blood glucose increases early after stroke onset:a study on serial measurements of blood glucose in acute stroke. Eur J Neurol. 2002;9:297-301.
17. Allport L. Baird T. Butcher K, MacGregor L, Prosser J, Colman P. Davis S. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care. 2006;29:1839-1844.
18. Stollberger C, Exner I, Finsterer J, Slany J, Steger C. Stroke in diabetic and non-diabetic patients:course and prognostic value of admission serum glucose. Ann Med. 2005;37:357-364.
19. Farrokhnia N. Björk E, Lindba7die;ck J, Terent A. Blood glucose in acute stroke, different therapeutic targets for diabetic and non-diabetic patients? Acta Neurol Scand. 2005:112:81-87.
20. Kiers L. Davis SM, Larkins R, Hopper J, Tres B, Rossiter SC. Carlin J. Ratnaike S. Stroke topography and outcome in relation to hyperglycemia and diabetes. J Neurol Neurosurg Psychiatry. 1992;55:263-270.
21. Candelise L, Landi G, Orazio EN, Boccardi E. Prognostic significance of hyperglycemia in acute stroke. Arch Neurol. 1985:42:661-663.
22. Cazzato G, Zorzon M, Mase G. Iona LG. Hyperglycaemia at ischemic stroke onset as prognostic factor. J Neurol Sci. 1991:12:263-270.
23. Williams LS, Rotich J, Fineberg N, Espay A, Bruno A, Fineberg SE. Tierney WR. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59:67-71.
24. Woo J, Lam CWK, Kay R, Wong HAY, Teoh R, Nicholla MG. The influence of hyperglycaemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol. 1990:47:1174-1177.
25. Gray CS. French JM, Bates D, Cartlidge NEF, Venables GF, James OFW. Increasing age. diabetes mellitus and recovery from stroke. Postgrad Med J. 1989;65:720-724.
26. Adams HP, Adams RJ, Brott T, del Zoppo GJ, Burlan G, Goldstein LB, Grubb RL, Higashida R, Kidwell C. Kwiatkowski TG, Marler JR, Hademenos GJ. Guidelines for the early management of patients with ischemic stroke. A scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056-1083.
27. Adams HP. del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higasdhida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstem LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EFM. Guidelines for the early management of adults with ischemic stroke. Stroke. 2007;38:1655-1711.
28. Baird TA, Parsons MW, Barber PA, Butcher KS, Desmond PM, Tress BM, Colman PG, Jerums G, Chambers BR, Davis SM. The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci. 2002:9:618-626.
29. Hall CE. Rogalsky-Nacca J, Chernavvsky DR, Johnston KC. Glucose regulation in acute stroke patients trial. International Stroke Conference:2007;San Francisco, CA.
30. Gray CS, Hildreth AJ, Alberti GKMM, O'Connell JE, on behalf of the GIST Collaboration. Poststroke hyperglycemia. Natural history and immediate management. Stroke. 2004;35:122-126.
31. Scott JF, Robinson GM. French JM, O'Connell JE, Alberti KGMM, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia. The Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30:793-799.
32. Walters MR, Weir CJ, Lees KR. A randomised controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis. 2006;22:116-122.
33. Gray CS, Hildreth AJ, Sandercock PA. O'Connell JE, Johnston DE. Cartlidge NEF, Bamford JM, James OF, Alberti GMM, for the GIST Trialists Collaboration. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia:the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 2007;6:397-406.
34. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, Kissela BM, Williams LS. Treatment of Hyperglycemia in Ischemic Stroke (THIS). A randomized pilot trial. Stroke. 2008;39:384-389.